DC
BIVI icon

Diametric Capital’s BioVie BIVI Stock Holding History

Diametric Capital’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$518K Hold
370,000
– – 0.13% 198
2025
Q4 		$429K Hold
370,000
– – 0.12% 263
2025
Q3 		$703K Buy
+370,000
New +$1.5M 0.26% 89

Other funds holding BIVI

PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Diametric Capital's BIVI Position: Q1 2026 in Review

Diametric Capital held its BioVie (BIVI) position steady in Q1 2026 at 370,000 shares worth $518K. The position accounts for 0.13% of the portfolio, ranked #198.

Diametric Capital first reported a position in BIVI in Q3 2025 and has held it in 3 quarters since. The position peaked at $703K in Q3 2025. 33 funds tracked by Wall St. Rank hold BIVI as of Q1 2026.

  • Diametric Capital held 370,000 shares of BioVie worth $518K as of Q1 2026.
  • Diametric Capital left its BioVie share count unchanged in Q1 2026.
  • BioVie made up 0.13% of Diametric Capital's portfolio in Q1 2026, its #198 holding.
  • Diametric Capital first reported a position in BioVie in Q3 2025 and has held it in 3 quarters since.
  • Diametric Capital's BioVie position peaked at $703K in Q3 2025.
  • 33 funds tracked by Wall St. Rank held BioVie as of Q1 2026.

Based on Diametric Capital's 13F filing for Q1 2026, filed 15 May 2026.